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Abstract 
 
Most bacteria live as biofilms (99%), which is a population of cells attached to a natural or artificial surface and encased in self-
produced exopolysaccharide matrix. The extracellular polymeric substances (EPS) in the matrix can vary greatly between species 
in chemical and physical properties, but primarily it consists of water, polysaccharides, proteins, nucleic acids and absorbed 
nutrients from the surrounding area. Biofilm formation appears to be a survival strategy of bacteria and the main purpose of the 
biofilm matrix is to protect the bacteria. In nature, biofilms have been found in variety of different environments, including humans.  
 
Bacterial biofilms demonstrate a decreased susceptibility to antimicrobial agents and several mechanisms have been proposed to 
be involved in this tolerance. One of the reasons why chronic infections develop is that the immune response fails to remove the 
biofilm. Most of the bacterial infections currently in developed countries are biofilm related and these infections are often 
recalcitrant and difficult to eradicate with available treatments. In addition to chronic infections, the treatment of acute infections is 
shadowed by increasing problems with highly resistant bacteria. 
 
The presence of dormant persisters in biofilms accounts for their tolerance to antimicrobials and likely are responsible for latent 
and chronic infections, such as tuberculosis. Persistence is not primarily an active mechanism of antibiotic tolerance, but a dormant 
state of the bacteria avoiding the mechanism of action of most antibiotics. Persisters form stochastically only in small numbers, and 
more relevant physiological explanation is related to the stress responses of the cells. Persisters are distinguish phenotypic 
variants of the normal population and it is not a heritable feature, as no mutations occur. 
 
The dormant, persistent state of the bacteria is largely responsible for the multidrug tolerance of recalcitrant infections. Biofilm 
cause various diseases in humans, as bacteria are able to attach to practically any surface, such as teeth, heart valves, lungs, 
middle ear, artificial prosthetics and instruments. Biofilms growing on prosthetic joints can cause also serious infections, which are 
painful for the patient with high risks for complications, expensive and laborious to replace. Biofilm infections are difficult to treat 
and a huge burden in the healthcare. Many acute infections can be cured with conventional antibiotic therapies, but this is not case 
with recalcitrant, chronic infections.  
 
B. cenocepacia belongs to the B. cepacia complex (Bcc) which consist of 20 closely related and phenotypically similar species. 
This species was chosen for this study because of its natural tolerance to antibiotics and ability to form biofilms easily. This species 
causes fatal lung infections in cystic fibrosis patients, and there is no treatment for it other than inadequate combination antibiotic 
treatment and lung transplant. 
 
In this thesis, a promising method was developed and validated for detecting anti-persister activity against B. cenocepacia. The 
assay is based on measuring the levels of ATP present in the cultures after treatment and it can be used quantify remaining 
persisters using B. cenocepacia biofilms. Utilizing the method validated, it was confirmed that mitomycin C is an effective anti-
persister compound against highly tolerant B. cenocepacia biofilms even at low concentrations. Doxycycline was found to be 
ineffective against B. cenocepacia biofilms, although the bacteria are susceptible to it in planktonic form, and ciprofloxacin was 
proved to be effective at very high concentrations. 
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Tiivistelmä 
 
Suurin osa bakteereista elää biofilmeinä (99%), eli populaationa soluja kiinnittyneenä luonnolliseen tai keinotekoiseen pintaan. 
Bakteeripopulaatio kätkeytyy itsetuotettuun eksopolysakkaridi limaan. Solun ulkopuoliset polymeeriset yhdisteet voivat vaihdella 
suuresti eri lajien välillä kemiallisilta ja fysikaalisilta ominaisuuksiltaan. Pääasiassa kuitenkin tämä lima koostuu vedestä, 
polysakkarideista, proteiineista, nukleiinihapoista ja ympäristöstä saaduista ravinteista. Biofilmin muodostus vaikuttaa olevan 
pääasiassa selviytymismekanismi bakteereille, ja biofilmin liman päätarkoitus onkin suojella bakteereita. Luonnossa biofilmejä 
esiintyy laajalti erilaisissa ympäristöissä, jopa ihmisessä. Bakteerien muodostamat biofilmit osoittavat heikentynyttä herkkyyttä 
antibiooteille ja useita mekanismeja tämän toleranssin taustalla on selvitetty. Kroonisia infektioita kehittyy mm. seurauksena siitä, 
että immuunipuolustus epäonnistuu tuhoamaan biofilmin. Suurin osa bakteeri-infektioista kehittyneissä maissa ovat biofilmien 
aiheuttamia ja nämä infektiot ovat usein hoitoon vastaamattomia nykyisillä hoidoilla. Kroonisten infektioiden lisäksi 
terveydenhuollon ongelmana on akuuttejakin infektioita aiheuttavien bakteerien kasvava resistenssi antibiooteille. 
 
Uinuvat persisterit biofilmeissä aiheuttavat niiden toleranssiin antimikrobeja vastaan ja persisterien ajatellaankin olevan syynä 
latentteihin ja kroonisiin infektioihin, kuten tuberkuloosiin. Persistenssi ei ole aktiivinen antibioottitoleranssin mekanismi, vaan 
ennemmin uinuva bakteerien tila, joka välttää useimpien antibioottien vaikutusmekanismin. Persistereitä muodostuu 
sattumanvaraisesti vain vähän ja oleellisempi fysiologinen selitys liittyy solujen stressireaktioon. Persisterit ovat erillinen fenotyyppi 
normaalista populaatiosta, eikä se ole periytyvää, sillä mutaatioita ei tapahdu. 
 
Bakteerien persistentti tila on suuresti vastuussa hoitoon vastaamattomien infektioiden monilääketoleranssista. Biofilmit aiheuttavat 
erilaisia sairauksia ihmisissä, sillä bakteerit voivat kiinnittyä lähes mihin tahansa pintaan, kuten hampaisiin, sydänläppiin, 
keuhkoihin, välikorvaan, keinoproteeseihin, ja instrumentteihin. Biofilmien aiheuttamat infektiot ovat vaikeita hoitaa, ja ne ovat suuri 
taakka terveydenhuollolle. Keinonivelissä kasvavat biofilmit voivat aiheuttaa vakavia infektioita, jotka ovat kivuliaita potilaalle, ja 
niissä on suuri komplikaatioiden riski. Keinonivelen infektiot tulevat kalliiksi ja työläiksi hoitaa, sillä paras hoito on usein sen 
vaihtaminen uuteen. B. cenocepacia kuuluu B. cepacia kompleksiin, joka koostuu 20:sta fenotyypiltään läheisestä lajista. Tämä laji 
valittiin tähän tutkimukseen sen luonnollisen toleranssin ja sen hyvän biofilmin muodostuskyvyn takia. Laji aiheuttaa fataaleja 
keuhkoinfektioita potilailla, joilla on kystinen fibroosi. Näihin infektioihin ei ole mitään hoitoa, riittämättömän antibioottihoidon ja 
keuhkosiirteen lisäksi. 
 
Tässä tutkielmassa kehitettiin ja validoitiin lupaava menetelmä persisterien vastaisen aktiivisuuden havaitsemiseksi B. 
cenocepacia biofilmejä vastaan. Menetelmä perustuu ATP pitoisuuksien mittaamiseen viljelmistä käsittelyn jälkeen. Menetelmää 
voidaan käyttää käsittelyn jälkeen jäljelle jääneiden persisterien määrän määrittämiseen käyttäen B. cenocepacia biofilmejä. 
Kehitettyä metodia käyttämällä vahvistettiin, että mitomysiini C on tehokas persisterejä tappava yhdiste tolerantteja B. cenocepacia 
biofilmejä vastaan myös erittäin pienillä pitoisuuksilla. Doksisykliini osoittautui tehottomaksi näitä biofilmejä vastaan, vaikka se oli 
tehokas planktonisessa muodossa kasvaviin bakteereihin. Siprofloksasiini oli tehokas biofilmejä vastaan vain erittäin korkeilla 
pitoisuuksilla. 
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1 INTRODUCTION 
 
Biofilms are present in more than 80 % of microbial infections according to the U.S. 
National Institutes of Health in 2015 (Donne and Dewilde 2015). There are 17 million 
new biofilm related infections every year in the United States of America, which lead to 
550 000 fatalities. Biofilm infections are difficult to treat and a huge burden in the 
healthcare (Bryers 2008). Many acute infections can be cured with conventional antibiotic 
therapies, but this is not case with recalcitrant, chronic infections (Alhede et al. 2014). 
Antibiotics can help the symptoms of a chronic infection and keep the acute phase in 
control, but as soon as the treatment is halted, the infection might resuscitate. This is 
mainly because of persisters, highly tolerant bacteria inside the biofilms. Dormant and 
non-dividing persisters are not affected by traditional antibiotics, which are primarily 
effective against growing cells.  
 
While resistance is a rising problem in the spotlight, and the need for novel antimicrobial 
therapies is obvious, tolerance is rarely discussed in such volume. As new antimicrobials 
are not frequently discovered, the need for novel targets, that would not be sensitive to 
resistance is evident. New targets like persisters or features contributing to the biofilm 
formation and intercell communication would be potential targets for novel antimicrobial 
therapies. Yet, persisters are not a new issue, as they were discovered in the 1940’s. Quite 
little is known of this phenotype, and there is urge for more knowledge. Persisters are 
rather difficult to study, and many different insights to the issue have been presented, with 
a few misperceptions (Kim and Wood 2016). The aim of this thesis was to find and 
validate a method for screening new compounds with anti-persisters activity. 
  
2 
 
 
2 LITERATURE REVIEW  
 
2.1 Biofilms 
 
Biofilm is the most common lifestyle for bacteria, and it is estimated that 99% of all 
bacteria live in biofilms (Donne and Dewilde 2015). Biofilms consist of two main 
components: the extracellular matrix (80-85%) and only 15-20% of it is bacteria or other 
microorganisms (Dufour et al. 2010). Biofilms can be formed by a single species, but also 
various species of bacteria can form a mixed biofilm. In addition to bacteria, also fungi, 
algae, yeasts and protozoa can form biofilms. In 1933 Henrici made an observation of 
this bacterial lifestyle and reported that “It is quite evident that for the most part the water 
bacteria are not free-floating organisms, but grow on submerged surfaces; they are of the 
benthos rather than the plankton” (Henrici 1933). 
 
Biofilm is a population of cells attached to a natural or artificial surface and encased in 
self-produced exopolysaccharide matrix  (Dufour et al. 2010; Lewis 2001). Biofilms are 
difficult to eradicate and cause many recalcitrant infections. In nature, biofilms have been 
found in variety of different environments e. g. thermal waters and frozen glaciers. In 
addition, biofilms can be found in extreme acidic environments with high metal content 
and low nutrients, and they can also thrive in very different hydration levels ranging from 
deserts to oceans (Dufour et al. 2010). Biofilms can grow in abiotic or living surfaces, 
also inside humans, and pathogenic biofilms are a relevant topic in the healthcare. Most 
of the bacterial infections currently in developed countries are biofilm related and these 
infections are often recalcitrant and difficult to eradicate with available treatments  (Høiby 
et al. 2010). In addition to chronic infections, the treatment of acute infections is 
shadowed by increasing problems with highly resistant bacteria.  
 
Apart from the notorious pathogenic reputation of biofilms, some biofilms are essential 
to humans, taking part in many vital processes e.g. in the production of vitamins and 
essential amino acids (Donlan 2002). Useful biofilms can also help prevent colonization 
by exogenous pathogens. There are also many advantageous roles for biofilms in the 
environment, e. g. functioning as symbiotic nitrogen fixer in plant roots. 
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2.1.1 Biofilm formation and structure 
 
Biofilms can be formed practically on any surface. There are certain key steps recognized 
in the process of biofilm formation. The first stage of biofilm formation is the initial 
attachment. In addition to passive movements, free-floating bacteria are able to swim 
towards favourable conditions with e. g. flagellum machinery and attach to surfaces 
(Beloin et al. 2008; Donne and Dewilde 2015). Physicochemical properties of the surface 
and the surrounding environment may exert a strong influence on the rate and extent of 
attachment (Donlan 2002; Purevdorj et al. 2002). Bacteria are able to overcome repulsive 
forces with flagella or pili, or there can exist hydrophobic or non-polar interactions 
between the cell surface and the substratum which enhance the irreversible attachment. 
When any surface is exposed to aqueous medium it will inevitably become conditioned 
or coated with polymers from that medium. These conditioning films will influence also 
the hydrodynamics and thus the attachment of bacteria to materials (Donlan 2002).  
 
Perhaps surprisingly, it has been observed that bacteria form biofilms preferably in 
conditions with high shear forces (Donlan 2002) . This can though, be explained by the 
hydrodynamics boundary layer, which substantially affects the interactions between cell 
surface and the substratum. The velocity characteristics of the liquid will influence the 
rate of settling of the bacteria and association of cells with a surface (Rijnaarts et al. 1993; 
Zheng et al. 1994). Planktonic bacteria behave as particles in liquid and under very low 
linear velocities the bacteria must cross broad hydrodynamic boundary layers, and contact 
with the surface would require high cell motility. As the velocity increases, the boundary 
layer decreases and the bacteria are exposed to greater turbulence and mixing. This is true 
until the velocities become high enough to exert shear forces to the attaching cells, and 
detaching them from the surface. Also, the properties of the medium (nutrients etc.) affect 
the attachment of the bacteria and growth of the biofilm (Donlan 2002; Purevdorj et al. 
2002). External physiochemical factors can affect the gene expression in biofilms, and 
attached cells may be involved in gene regulation of other cells by complex regulatory 
pathways (Donlan 2002). Along with environmental factors, properties of the microbial 
cell, presence of fimbriae, flagella or pili and production of surface associated 
polysaccharides or proteins all influence the rate and extent of attachment. 
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Biofilm can be flat or mushroom shaped, depending on the environment, nutrient source 
and the motility machinery present (Hall-Stoodley et al. 2004; Patriquin et al. 2007). Low 
oxygen, limitations in iron ions or sub lethal concentrations of antibiotics can enhance 
biofilm formation (Götz 2002; Patriquin et al. 2007). The extracellular polymeric 
substances (EPS) in the matrix can vary greatly between species in chemical and physical 
properties, but primarily it consists of water, polysaccharides, proteins, nucleic acids and 
absorbed nutrients from the surrounding area. EPS account for 50-90% of the organic 
carbon of biofilms. Biofilm formation appears to be a survival strategy of bacteria and 
the main purpose of the biofilm matrix is to protect the bacteria (O'Toole et al. 2000). The 
matrix composition is extremely important for the properties of the biofilm and it gives 
protection from various environmental challenges like antibiotics or host’s immune 
system (Gunn et al. 2016). Bacteria can live also in a form similar to biofilm, as 
aggregates, when bacteria attach to each other only, and no surface is involved (Alhede 
et al. 2011). 
 
There are multiple strategies for the bacteria to detach from the biofilm (Donlan 2002). 
Biofilm cells may shed as daughter cells of actively growing cells, detach as a result of 
changes in the environment, due to quorum sensing signals (or other signals) or shearing 
of biofilm aggregates because of shear stress. Many observations from the nature can be 
applied to situations in humans, as basics of biofilm growth and dispersal are alike (Hall-
Stoodley et al. 2004). Although mixed-species biofilms thrive in most natural 
environments, single-species biofilms cause in a variety of infections and live on the 
surface of medical implants. 
 
2.1.2 Biofilm as a bacterial lifestyle 
 
Both the environment and genes play important and complex roles in biofilm 
development (Hall-Stoodley et al. 2004). The proximity of cells inside the biofilm or 
aggregates provide an ideal opportunity for gene exchange and bacterial communication. 
To adapt to the changes of the environment, bacteria are able to utilize this specific 
mechanism of bacterial communication. Bacteria cells emit and detect small diffusing 
compounds to evaluate the population’s size and to express specific genes according to 
the population size and the environment (Brackman et al. 2009). These diffusible signal 
molecules are produced constantly, but at a low population density they provoke no effect. 
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This kind of intercellular communication between bacteria is called quorum sensing (QS). 
When population density is sufficiently high, the signal molecules bind to the receptors 
inducing or repressing transcription of QS-regulated genes. As an example, gram-
negative species belonging to the family of Burkholderia utilize multiple QS systems such 
as N-acyl-homoserine lactone (AHL)-dependent system for intercell communication 
(Schmid et al. 2012; Sokol et al. 2007). With QS, bacteria can adapt to different levels of 
nutrients in the environment, defend against competitive microorganisms and avoid toxic 
materials (Galloway et al. 2011). QS is also needed for invading or infecting a host. 
 
QS is not the sole mechanism responsible for biofilm formation and the virulence of the 
bacteria, there are other signals from the environment that can control biofilm formation 
and structure as well (Purevdorj et al. 2002). Although QS is a promising target for new 
antimicrobials, these kinds of compounds seem to mostly just enhance the effect of other 
antimicrobials, by weakening the biofilm  (Brackman et al. 2009). There are many other 
pathways included in the biofilm formation and interfering with QS does not completely 
block the biofilm from forming, but might have a weakening effect. This might be useful, 
when therapies are combined with antibiotics. One benefit in targeting the QS as an anti-
biofilm tactic is that QS inhibitors are typically used in concentrations below the minimal 
inhibitory concentration (MIC) and thus it is less likely that they would impose a selective 
pressure for the development of resistance.  
 
Biofilm formation and surface adhesion provide many advantages for the bacteria, 
tolerance and virulence of biofilms are characteristic to the lifestyle (Hall-Stoodley et al. 
2004). The matrix of the biofilm can protect the bacteria from antimicrobials by slowing 
physically the penetration of antibiotic or bind antibiotics directly to the EPS  (Donlan 
2002). Shiau and Wu (1998) showed that the extracellular polymeric substance matrix 
produced by Staphylococcus epidermidis interfered with macrophage phagocytic activity. 
The biofilm matrix provides also protection from immune system, and can slow the 
penetration of some antibiotics by negatively charged polymers  (Fux et al. 2005). A solid 
surface provides also stability in the growth environment. Biofilm present a selective 
barrier for the immune system, and it has been also shown that human leukocytes are able 
to penetrate the biofilm, but unable to engulf the bacteria present in the biofilm  (Leid et 
al. 2002). This suggests that there is another mechanism that inhibits normal leukocyte 
function within the biofilm. Leukocytes can possibly penetrate the biofilm through 
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nutrient and flow channels present in the biofilm (Bjarnsholt et al. 2005). This supports 
the observation that biofilms are more like extremely porous hydrogels than solid rigid 
structure. 
 
2.1.3 Biofilm recalcitrance 
 
Bacterial biofilms demonstrate a decreased susceptibility to antimicrobial agents and 
several mechanisms have been proposed to be involved in this tolerance. One of the 
reasons why chronic infections develop is that the immune response fails to eradicate the 
biofilm. This deficiency appears to be independent of the localization of the biofilm in 
the host (Bjarnsholt et al. 2009). 
 
It has been suggested that antibiotic treatment and the presence of host’s immune cells 
induces defence mechanism in biofilms (Jensen et al. 2007). The polymorphonuclear 
leukocytes (PMNs) constitute the most abundant of the circulating leukocytes that are 
normally the first phagocytes to appear in high numbers at the site of infections. The 
major role of the PMNs in acute inflammation is to phagocytize microorganisms and 
foreign materials (Bjarnsholt et al. 2005). The QS controlled production of rhamnolipids 
by the bacteria have been shown to disable the PMNs in Pseudomonas aeruginosa  
(Jensen et al. 2007). A range of antibiotics have been examined for their effects on QS-
regulated virulence factors like rhamnolipids, and many conventional antibiotics have 
shown to exert strong QS-inhibitory activity in P. aeruginosa (Skindersoe et al. 2008).  
 
Efflux pumps are involved in bacterial multidrug resistance, but it is not completely clear 
if effluxes are also involved in the mechanism of tolerance (Van Acker and Coenye 2016). 
It is known that inhibiting efflux pumps weakens the biofilm and may block maturation 
of biofilm  (Baugh et al. 2014; Kvist et al. 2008). This might influence the virulence of 
the bacteria, since virulence is linked to the ability to form biofilm. However, it seems 
that the connection of efflux pumps to resistance is more relevant than the link to 
persistence (Kim and Wood 2016). Both phenomena tolerance and resistance are 
clinically relevant in chronic infections, though they are not related my mechanism.  
 
It appears that another main immune defence, the production of reactive oxygen species 
(ROS), has a side effect of activating both classical resistance and multidrug tolerance in 
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pathogen cells (Wu et al. 2012). ROS induce oxidative stress, but by doing that, the 
concentration of antibiotics may decrease in the cell increasing the level of surviving 
persisters and their tolerance to this and other antibiotics, worsening recalcitrance.  
 
There are several features in the biofilm recalcitrance, but it seems that the main reason 
behind the tolerance lays in the dormant phenotypic variants of the normal population 
(Lewis 2010). Because antibiotics kill cells by corrupting specific targets in actively 
dividing and growing cells, dormant cells, in which the antibiotic targets are inactive, 
avoid killing (Wu et al. 2012). These non-growing, dormant cells expressing the specific 
temporary phenotype are called persisters. 
 
2.2 Persister cells 
 
Persister cells were first described in one of the first studies on the mechanism of 
penicillin action by Joseph W. Bigger in 1944 (Bigger 1944). In the experiment, Bigger 
discovered that a Staphylococcus aureus culture killed with penicillin could regrow in the 
absence of the antibiotic. This new culture could be lysed again with penicillin, yet again, 
a small subculture survived. These surviving cells were named as “persisters” to 
differentiate them from resistant bacteria, which can grow in the presence of the 
antibiotic. The tolerance of persisters to antibiotics is non-heritable and reversible (Keren 
et al. 2004). Although persisters were discovered right after the discovery of antibiotics, 
they were not studied for almost four decades. The main reason why persister were 
forgotten after their discovery was the tiny fraction of persisters in cultures and difficulty 
to isolate them with the techniques available at the time.  
 
In the 80’s Moeyd discovered high persister mutants (hip) of Escheria coli and this 
discovery attracted attention to the subject again  (Moyed and Bertrand 1983). It was not 
until a decade later when interest in persisters was notably increasing after the discovery 
of these high persister mutants. In the 1990’s resistance was developing faster than the 
discovery of new antibiotics and chronic infections were on the rise due to increasing use 
of indwelling devices and the rise in immunocompromised patients owing to cancer 
chemotherapy and HIV (Lewis 2010). 
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Persister cells are dormant phenotypic variants of regular cells and are highly tolerant to 
antibiotics (Wu et al. 2012). Cells can enter this dormant state spontaneously or through 
different mechanisms induced by the environment (Kwan et al. 2013). Persisters neither 
die or nor grow in the presence of antibiotics because antibiotics are unable to disturb 
cellular processes in a cell with globally reduced metabolism. The dormant, persistent 
state of the bacteria is largely responsible for the multidrug tolerance of recalcitrant 
infections. Chronic infections can be typically restrained but not eradicated completely 
with existing antimicrobials. The presence of dormant persisters in biofilms accounts for 
their tolerance to antimicrobials and likely are responsible for latent and chronic 
infections, such as tuberculosis. 
 
Persisters are found in all phases of cell growth, with a frequency of 0.0001 to 0.001% of 
the population in exponential-phase cultures and as high as 1% in biofilms and stationary-
phase cultures (Kwan et al. 2013; Shah et al. 2006). Persisters are distinguish phenotypic 
variants of the normal population and no mutations occur, thus it is not a heritable feature 
(Figure 1)  (Keren et al. 2004). It is however important to notice that non-dividing cells 
in stationary phase are not persisters, even though they behave like persisters (Lewis 
2007). These non-persister cells will start dividing soon although they are not dividing at 
the moment of measurement.  
 
 
Figure 1. Keren et al. (2004) repeated the experiment made by Bigger in 1944, where a 
bacterial culture was treated with ampicillin several times after reviving it in the absence 
of the antibiotic, and the strain remains sensitive to the antibiotic, behaving differently 
than the resistant strain.  
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2.2.1 Mechanism of persister formation 
 
Persistence is not primarily an active mechanism of antibiotic tolerance, but a dormant 
state of the bacteria avoiding the mechanism of action of most antibiotics (Wood et al. 
2013). Various descriptions of persister cell characteristics and for mechanism of persister 
formation have been proposed, but foremost persisters are dormant cells that halt protein 
synthesis (Kim and Wood 2016; Kwan et al. 2013). The proposed mechanisms leading to 
arrested protein synthesis include toxin-antitoxin modules, stringent response through the 
alarmone guanosine penta- or tetraphosphate (p)ppGpp, and to some extent spontaneous 
formation (Maisonneuve and Gerdes 2014). Lack of nutrients like amino acids and other 
environmental cues increase persister cell formation  (Kwan et al. 2013). Persisters form 
stochastically only in small numbers, and more relevant physiological explanation is 
related to the stress responses of the cells. Expression of the SOS response to 
(deoxyribonucleic acid) DNA damage by fluoroquinolone treatment induces formation 
of persisters by increasing expression of a specific toxin. Also, induction of a classical 
resistance mechanism, multidrug-resistant (MDR) efflux pump, by oxidative stress leads 
to an increase in persister cells (Wu et al. 2012). 
 
One of most studied mechanism for persister formation is toxin-antitoxin (TA) modules 
(Lewis 2010). Typically, the toxin part of the module is a protein that inhibits an important 
cellular function. The antitoxin counterpart forms an inactive complex with the toxin, and 
no damage to translation or replication occurs. Under specific stresses, antitoxins are 
degraded and the resulting active toxins inhibit cellular processes, which eventually leads 
to persister formation (Gerdes and Maisonneuve 2012). TA modules were first linked to 
persisters in 2006 (Shah et al. 2006). TA modules are prevalent in bacterial genome and 
they play an important role in persister formation (Gerdes and Maisonneuve 2012). To 
activate the TA systems leading to persistence, the cell must respond to stress (Korch et 
al. 2003). This stress response is thought to be propagated through the alarmone 
guanosine tetraphosphate (ppGpp) which is produced during nutrient limitation (stringent 
response) and other stresses (Maisonneuve et al. 2013). It has been suggested that the 
ppGpp mediating the stringent response activates Lon protease through polyphosphate, 
and subsequently Lon inactivates antitoxins of TA systems freeing the toxin to reduce 
metabolism. PpGpp has been linked to persistence before, but Maisonneuve et al. (2013) 
made conclusion that the ppGpp activates Lon protease via polyphosphate (Korch et al. 
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2003). However, there is a controversy to this conclusion, as it has been showed that 
ppGpp and polyphosphate rather inactivate Lon protease (Osbourne et al. 2014). In cells 
unable to produce ppGpp, persister cells are still formed, so there must be other 
mechanism for persister formation (Chowdhury et al. 2016). It has been also studied that 
many TA systems were still able to increase persistence in the absence of ppGpp.   
 
Although many mechanisms behind persistence has been studied, the connection between 
an identified mechanism and persister formation seem to be controversial, and there are 
quality and consistency issues in many studies (Kim and Wood 2016). This proves that 
persistence is still today a difficult subject to study, and the basic methods need validation. 
The study of anti-persisters could be a straight-forward continuum to the studies of 
antimicrobials, but the insights into the mechanism leading to persistence are varying and 
the complexity of the studies is increased since there is not one protein responsible for 
the phenomenon  (Chowdhury et al. 2016). Also, there are many errors abound in the 
techniques studying persisters with many waking the cells with fresh medium leading to 
the activation of the phenotype, and non-persister cells are studied eventually (Kim and 
Wood 2016). As microbial infections are the leading cause of death worldwide and 
persister cells being the main reason for recurring infections, the need for more accurate 
details for the mechanism of persister cell formation is evident (Lewis 2007; Rasko and 
Sperandio 2010). 
 
2.2.2 Medical challenge of tolerant persisters 
 
Treatment of bacterial infections is distracted by the two distinct phenomena of bacterial 
persistence and resistance through unrelated mechanisms (Lewis 2007). Persisters in 
biofilms seem to be the main reason for recalcitrant infections. Some of the reasons why 
biofilms are so difficult to eradicate are restricted penetration of antimicrobials, decreased 
growth rate and expression of possible biofilm-specific resistance genes. But these 
reasons do not explain solely the tolerance of biofilms. As Lewis and his group observed 
in their study, persisters are ultimately responsible for the resistance of the biofilm to 
killing (Brooun et al. 2000; Keren et al. 2004). It was observed that a small subpopulation 
survived the antibiotic treatment, and killing did not increase with antibiotic concentration 
after certain point. Most cells in a biofilm are not necessarily more resistant to killing than 
planktonic cells and die rapidly when treated with a bactericidal antibiotic that can kill 
11 
 
 
also slowly growing cells (Lewis 2001). Persisters survive this treatment and are actually 
preserved by the presence of an antibiotic that inhibits their growth. Paradoxically, the 
antibiotic aids persisters to persevere.  
 
This bi-phasic killing has been observed previously also, but the role of persisters in 
biofilm resistance had not been considered in literature before 2000 (Brooun et al. 2000; 
Lewis 2001). The antibiotics developed since the 40’s have been effective against 
previously life-threatening acute infections, but there are no specific treatments for 
biofilm infections even today. Now biofilm caused infections are treated the same way as 
the infections caused by planktonic microbes (Donlan and Costerton 2002). Bacteria in 
biofilms can attach to practically any surface, on artificial surfaces and on dead or living 
tissue. Biofilms formed under high shear environments are stronger than on low-shear 
environments. Despite the clinical relevance, there are currently no viable means for 
eradicating persisters in vivo. However, Kwan and his team  (Kwan et al. 2015) have 
studied an anti-cancer drug, Mitomycin C (MMC), and it seems to be working in vitro 
against persisters at concentrations applied in cancer treatments clinically. 
 
2.3 Biofilm in chronic infections 
 
Bacterial biofilms consist of self-produced matrix protecting the cells attached to a 
surface and to each other (Bjarnsholt et al. 2009; Costerton et al. 2003). The matrix 
provides structural stability and protection against threats, like antibiotics and immune 
cells (Costerton et al. 1999). It was almost four decades ago, when the direct correlation 
between development of biofilms and persistent infections was suspected. The first to 
state this notably in the case of Pseudomonas aeruginosa colonizing the lungs of CF 
patients were N. Høiby, J. W. Costerton, and their collaborators (Lam et al. 1980; 
Lebeaux et al. 2014). 
 
Biofilm cause various diseases in humans, as bacteria are able to attach to practically any 
surface, such as teeth, heart valves, lungs, middle ear, artificial prosthetics and 
instruments (Høiby et al. 2010). The presence of biofilms is often associated with chronic 
infections in clinical settings due to its tolerance toward antimicrobial agents and host 
immune defence. In contrast, acute bacterial infections are short-term because they 
involve susceptible, planktonic bacteria, which are rather easily eradicated with 
12 
 
 
antibiotics together with the host’s immune system. It is clear, that classical antibiotic 
resistance mechanism such as upregulated efflux pumps play small part in the ability of 
biofilms to tolerate antibiotic treatment (Høiby et al. 2010). Bacteria have many defence 
mechanisms related to biofilm lifestyle such as producing virulence factors unique to 
biofilms. For example, it has been established that rhamnolipids produced by P. 
aeruginosa work as defence against polymorphonuclear leukocytes (PMN’s) (Jensen et 
al. 2007). 
 
2.3.1 Chronic wounds 
 
In developed countries as many as 2 % of the population is estimated to develop chronic 
wounds, a condition associated with reduced quality of life, and high costs to the health 
care system (Fazli et al. 2009). As growing populations of people suffer from diabetes 
and cardiovascular diseases, it increases problems with chronic wounds. In these diseases, 
wounds are formed due to a dysfunction of the venous valves causing hypertension in the 
veins of legs, followed by increased pressure in capillaries and swelling. These wounds 
are poorly healing, which leads them highly susceptible to bacterial infections. Normally, 
a wound would heal in four main phases: coagulation, inflammation, cell proliferations 
and epithelialization. However, the disturbance in the inflammation phase leads to 
chronic wounds. One major part of the inflammation process is the elevated activity of 
PMNs, which produce tissue damaging factors, like free oxygen radicals to their 
surroundings. Other interesting feature is, that the tissue damaging factors produced by 
PMNs, might provoke the cells in the biofilm to persister mode, making the biofilm in 
the wound even more difficult to eradicate (Jensen et al. 2007). As the biofilms offers 
protection from PMNs, they are not able to reach their target inside the biofilm (Bjarnsholt 
et al. 2008). At least P. aeruginosa is known to produce rhamnolipids that offer shield 
against the activities of host immune cells. 
 
2.3.2 Lung infections in immunocompromised patients 
 
Cystic fibrosis (CF) is a life-limiting genetic disorder, with highest prevalence in Europe, 
North America, and Australia (Elborn 2016). The disease is caused by mutation in a gene 
of a chloride-conducting transmembrane channel called the cystic fibrosis transmembrane 
conductance regulator (CFTR). There are several hundreds of known mutations that cause 
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CF and the range of types of mutations is wide (Koch and Høiby 1993). CFTR functions 
as regulator of anion transport and mucociliary clearance in the airways (Elborn 2016). 
The malfunctioning CFTR causes dehydration in the respiratory epithelium due to 
decreased secretion and increased reabsorption of electrolytes and water. The secretions 
covering the respiratory epithelium are thickened and pulmonary clearance is decreased. 
This leads inevitably to chronic infections and subsequently in local airway inflammation 
that is harmful to the lungs. Progressive bacterial infection in the lungs leading to 
respiratory failure is the most common cause of death in CF patients. Burkholderia spp. 
are among P. aeruginosa the most common pathogens to cause pulmonary infections in 
CF patients  (Jones et al. 2004; Singh et al. 2000). 
 
There is no curable treatment for CF or the lung infections in CF. Once the CF lung has 
been colonized, even long-term antibiotic therapy does not eradicate the infection (Singh 
et al. 2000). The antibiotic resistance of P. aeruginosa in the CF lung arises from the 
innately resistant biofilm form of bacteria. The challenges in treating pulmonary 
infections of CF patients, is that antibiotics have been developed and are chosen in 
practise according to their effectiveness against planktonic bacteria, although the bacteria 
grow in biofilms or aggregates in the lung  (Costerton et al. 1999; Lam et al. 1980).  
 
Chronic granulomatous disease (CGD) is a rare immunodeficiency disease resulting from 
genetic defects in phagocyte NADPH-oxidase, shifting the patient’s phagocytes unable 
to produce the reactive oxygen species (ROS) needed for proper antimicrobial activity. 
In chronic granulomatous disease Burkholderia cenocepacia can infect the lungs of 
patients and cause life threatening infections (Brackman et al. 2009; Bylund et al. 2005). 
 
2.3.3 Fatal cepacia syndrome 
 
Burkholderia cepacia complex (Bcc) species are notoriously antibiotic resistant and 
practically impossible to eradicate from CF lung infections (Sokol et al. 2007). In some 
cases, infection with B. cenocepacia results in a rapid deterioration in lung function, 
characterized by necrotizing pneumonia, bacteraemia and sepsis, referred to as “cepacia 
syndrome”. Pulmonary colonization of B. cenocepacia in CF patients can cause fatal 
cepacia syndrome that accelerates decline in lung functions, and is essentially untreatable 
(Jones et al. 2004). This condition is different, and more serious than other lung infections 
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in CF patients, and cepacia syndrome is rare in other than CF patients. The trouble treating 
this condition comes from the intrinsic resistance of B. cenocepacia to antibiotics (Selin 
et al. 2015).  
 
2.3.4 Infections of indwelling devices  
 
In many medical conditions, it is necessary to implant a medical device inside the body 
of a patient. As biofilms can thrive on practically any surface, they may grow on 
indwelling devices also (Costerton et al. 1999). About 2/3 of nosocomial (hospital 
acquired) infections are associated with some type of implanted medical device (Bryers 
2008). Most commonly used indwelling medical devices (IMD) are urinary and 
intravascular catheters and microbial infections on these devices are common. Microbial 
infection can also occur in e. g. artificial heart valves, orthopaedic implants, cardiac 
pacemakers, ocular prostheses, dental implants and contact lenses (Bryers 2008; Donlan 
and Costerton 2002).  
 
For infections of some uncomplicated and nonsurgical IMD’s, such as contact lenses, the 
trouble is low, and the implant can be easily replaced. However, catheter-related biofilms 
can cause bloodstream infections leading to bacteraemia with a significant attributed cost 
and a high probability of secondary complications including infective endocarditis, septic 
emboli, and stroke (Lynch and Robertson 2008). Biofilms growing on prosthetic joints 
can cause also serious infections, which are painful for the patient with high risks for 
complications, expensive and laborious to replace (Barberán 2006). When an IMD, such 
as artificial joint, is infected with biofilm, it is usually treated with a course of 
antimicrobials, but often it is not enough to eradicate the infection and the IMD must be 
replaced surgically. Another case of infection on implanted devices is tissue fillers 
(Alhede et al. 2014). Tissue fillers such as gels or silicones are extensively used in the 
cosmetic business. As with other implanted devices, the use of tissue fillers has led to 
adverse effects in terms of infections. (Bjarnsholt et al. 2009) 
 
2.3.5 Other biofilm related diseases 
 
The microbial colonies in the oral environment are another example of a complex biofilm 
system. Pathogenic oral biofilms can cause local infections such as dental caries or 
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periodontitis (Bryers 2008; Marsh 2006). Microbes originating from gingival tissue can 
enter the blood stream in the event of a disruption, for example in dental procedure.  
Microbes entering the bloodstream from gingival cavities can cause life-threatening 
endocarditis (Donlan and Costerton 2002). Endocarditis can cause severe complications, 
as microcolonies can detach from the biofilm attached to the heart valve and cause 
infective emboli. 
 
One particularly tolerant and notorious biofilm infection is tuberculosis. It is typically 
caused by Mycobacterium tuberculosis and usually occurs in the lungs, but may affect 
practically any organ system. The condition is potentially life-threatening, and is usually 
treated with an extended course of several bactericidal antimicrobials combined (Liippo 
2010). It is estimated that 2 billion people worldwide are infected with M. tuberculosis 
and it cause an estimated almost 2 million deaths each year (Tufariello et al. 2003). 
Primary infection leads to active disease in only a minority of infected people, and in rest 
cases the infection is contained by the immune system. The presence of granulomas, 
formed by the host’s immune cells, has an influence on the tolerance of tuberculosis 
against treatment and contributes to the latency. These granulomas have altered 
microenvironments ideal for persister formation and favour also other states of dormancy. 
Characteristic of tuberculosis is that it prevails as latent infection at most cases, being 
non-infective and not causing symptoms, but when host’s immune system is perturbed, 
the reactivation of latent infection can occur. 
 
2.4 Burkholderia cenocepacia 
 
The first member of the Burkholderia family, Burkholderia cepacia was originally known 
as Pseudomonas cepacia (Burkholder WH 1950). B. cenocepacia belongs to the B. 
cepacia complex (Bcc) which consist of 20 closely related and phenotypically similar 
species  (Lewis and Torres 2016). These gram-negative, rod-shaped bacteria are obligate 
aerobes and have diverse ecological niches. Bcc bacteria are equipped appendage pili of 
at least five different kinds (Goldstein et al. 1995). These adhesive structures are needed 
for the initial stages of biofilm formation  (Coenye 2010). Bcc species are abundantly 
found in the environment, especially in the soil, and have non-pathogenic interactions 
with plants (Coenye and Vandamme 2003). Some Bcc species are plant pathogens, but 
can cause also infections in mammalians. Bcc isolates have been exploited for various 
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purposes, including biological control of plant pathogens and plant growth promotion. In 
humans, these opportunistic bacteria cause respiratory tract infections in 
immunocompromised patients, especially in people suffering from cystic fibrosis, but 
also people with chronic granulomatous disease (Brackman et al. 2009). Most commonly 
isolated species from Bcc infections in patients with CF are B. multivorans and B. 
cenocepacia (Lipuma 2010). Antimicrobial treatments fail often, because these bacteria 
form biofilms easily and have intrinsic resistance and tolerance against antibiotics. 
 
Chronic Burkholderia infections share some persistence factors and host immune evasion 
strategies with other persistent bacteria, such as M. tuberculosis and P. aeruginosa 
(Coenye 2010). B. cenocepacia biofilms are highly resistant to certain disinfectants also, 
such as hydrogen peroxide (Lefebre and Valvano 2001). There has been identified several 
different exopolysaccharides produced by Bcc species, that are likely to be involved in 
persistence and invasiveness. Chlorhexidine exposure activates multiple efflux pump 
proteins in these bacteria and at least some of the RND efflux pumps are lifestyle-specific 
to the biofilm state (Coenye et al. 2011). 
 
2.5 Tolerance and resistance 
 
Antibiotic resistance is a well-known phenomenon where microbial populations obtain 
mutations that render them insusceptible to certain antibiotics. Bacterial persistence is a 
different phenomenon by mechanism. In persistence, small fraction of bacterial 
population can survive lethal doses of antimicrobial agents while the population as a 
whole remains susceptible (Dörr et al. 2009). Resistant microbes can grow in the presence 
of an elevated level of an antimicrobial, and the strain’s minimum inhibitory 
concentration (MIC) is increased  (Lewis 2001). Antimicrobial resistance is a distinct 
phenomenon when bacteria are able to prevent the interaction of an antibiotic with a target 
by various mechanisms (Lewis 2010). Essentially, antimicrobial tolerance is a property 
of dormant cells, surviving antibiotic treatments in the absence of drug resistance 
mechanisms. The search for treatments of bacterial infections is complicated because of 
both bacterial resistance and persistence, which are two distinguish phenomena occurring 
through unrelated mechanisms. 
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Moyed and his team noticed in the 1980’s, that high persistent bacteria strains had the 
same minimal inhibitory concentration (MIC) value than normal strains, though the 
persistent bacteria is not killed by antimicrobials. Work of Moyed in the 1980’s was 
forgotten for a while like Biggers on 1940’s. High persistent, but not resistant strain can 
produce 1000-times more persisters, but has the same MIC. Although persisters can form 
stochastically, especially in static cultures as a result of fluctuations in gene expression, 
it has been show that persistence is also induced by a variety of environmental factors 
(Orman and Brynildsen 2013) 
 
Two forms of bacterial dormancy, persistence and viable but non-culturable state are 
usually described as two different phenomena, but they share some similarities according 
to Ayrapetyan’s team (2015). Both forms of dormancy are highly tolerant against 
antibiotics, and they are induced by similar environmental cues (Jayaraman 2008). Also, 
the molecular mechanism that controls persistence or VBNC state seems to be similar (e. 
g. TA-modules and stringent response). These states of dormancy able to tolerate high-
dose antibiotics, they can be induced by common environmental cues and share molecular 
mechanisms that control dormancy, which implies that they are closely related states and 
develop through shared mechanisms  (Orman and Brynildsen 2013). 
 
2.6 Techniques used in persister and biofilm studies 
 
For decades, bacteria have been studied in shaken cultures and most often in exponential 
growth, that is, the archetype of the planktonic life form where they are free floating cells. 
These growing, planktonic cultures have been the basis for antibiotic screenings ignoring 
the biofilm mode of growth for decades. With the significance of biofilms in chronic 
infections, tolerance to antibiotics is further challenge for treatment of chronic infections. 
To understand the biofilm mode of growth in the in vivo setting, the biofilm lifestyle of 
P. aeruginosa has been studied in laboratory settings as surface grown biofilms. Assays 
using microtiter plates in combinations with crystal violet and resazurin have been 
developed to study surface-attracted biofilm-forming bacteria (Alhede et al. 2014). 
 
The main methodologies to study persisters are still unchanged from the times of their 
discovery; the susceptible population is eliminated with antimicrobials and the remaining 
bacteria is studied  (Cañas-Duarte et al. 2014; Maisonneuve et al. 2013). To gain most 
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persister possible, the culture is usually grown until stationary phase. Another method 
utilized to study persisters is the fluorescence-assisted cell sorting (FACS) (Shah et al. 
2006). This method can be used to isolate the dormant cells according to their 
transcriptional activity. Cells are first genetically modified to express green fluorescent 
protein, so that the level of fluorescent protein correlates to transcriptional activity. The 
cells are sorted by the amount of emitted green fluorescence. Dimmer fluorescence equals 
to an expression profile associated with the dormant persister state, and the cells can be 
found highly tolerant to antibiotics. 
 
Persisters can be studied by different methods, but caution is advised for making 
conclusion of results, as artificially induced persisters may not be equal to naturally 
occurring persisters (Kwan et al. 2013). Dormancy induced artificially should be regarded 
as persister-like state and distinguish from the dormancy of naturally (i. e., regulated by 
TA systems) forming persister cells. Persistence can be induced in vitro by compounds 
mimicking the activity of toxins, or generating overexpression of a toxin by an inducible 
plasmid. Antibiotics can exert an effect relatable to toxin when halting protein synthesis, 
and are frequently used to isolating persisters. 
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3 AIMS OF THE STUDY 
 
There are handful of strategies to study persisters in general, but only a fraction of those 
have been proven to work with B. cenocepacia. It’s a species that was chosen for the 
study because of its ability to form easily biofilms and persisters. This bacteria strain is 
interesting also for its intrinsically tolerant nature and the lack of proper treatments 
against infections caused by it. The species causes fatal lung infections in CF patients, 
and there is no treatment for it other than inadequate combination antibiotic treatment and 
lung transplant. 
 
The aim of the study was to develop an assay for studying persisters in B. cenocepacia 
biofilms, that could be ultimately applicable for chemical screens of anti-persister agents. 
The growing of this strain was new to the lab, and to develop an screening assay, some 
basic techniques had to be optimized, including growth conditions optimization and 
susceptibility testing. To have coherent results, it is important that the assay has high 
repeatability and robustness. These characteristics are assessed with various statistical 
parameters like screening window coefficient (Z’), signal to background ratio (S/B) and 
signal to noise ratio (S/N). 
 
The objective was to find a valid method to evaluate the viability of the remaining bacteria 
(persisters) after a chemical treatment. Several assays were tried out, and one of the 
methods was demonstrated to be functional. Stainings such as crystal violet and resazurin 
were used in susceptibility testing, and other techniques such as viable count 
determination and luminescent assay kit were utilized in developing the screening method 
in this study. Since the screening method developed was novel, validation was required 
to prove the concept. With a validated screening method for anti-persisters it would be 
possible to identify potential compounds from e.g. natural compound library in primary 
screenings. 
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4 MATERIALS AND METHODS 
 
4.1 Materials 
 
4.1.1 Bacteria strain 
 
The strain mainly used (Burkholderia cenocepacia DSM 16553) was obtained from 
HAMBI collection University of Helsinki (Faculty of Agriculture and Forestry, Division 
of Microbiology and Biotechnology) and stored as cryostocks in -80 °C in mixture of LB 
with 20 % glycerol. 
 
4.1.2 Reagents and equipment 
 
Antibiotics (ciprofloxacin, doxycycline and tobramycin), methanol, ethanol, glycerol, 
crystal violet and resazurin sodium salt were purchased from Sigma-Aldrich (St- Louis, 
Missouri, USA). Luria-Bertani (LB) broth and LB agar were obtained from LAB M 
limited (Heywood, UK), Mitomycin C (MMC) was purchased from Cayman Chemical 
Company (Ann Arbor, Michigan, USA). Phosphate buffered saline (PBS) was acquired 
from Lonza (Basel, Switzerland) and dehydroabietic acid was obtained from Wako Pure 
Chemical Industries (Osaka, Japan). Nunclon™ Delta Surface polystyrene flat-bottom 
96- microwell plates with clear or white bottoms were purchased from Thermo Fisher 
Scientific (Nunc; Roskilde, Denmark). Absorbance, fluorescence and luminescence 
measurements were carried out with a Thermo Fisher Varioskan LUX multiplate reader 
(Vantaa, Finland). ATP stock solution was obtained from BioThema (Handen, Sweden). 
 
4.2 Methods 
 
4.2.1 Cultivating the bacteria 
 
The pre-cultures were grown overnight in 50 ml Falcon tubes using 20 µl of the glycerol 
stock in 6 ml LB.  Tubes were incubated under aerobic conditions in 37 ˚C with 220 rpm 
aeration. For the exponential growth, the pre-culture was diluted 1:10 and grown for 
approximately 4 hours until optical density was 0.3 – 0.5 to reach the mid-exponential 
phase. Absorbance was measured from 200 µl volume of bacterial suspension in a well 
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of a microplate with Varioskan Lux at wavelength 595 nm. The mid-exponential culture 
achieved was then further diluted to gain optimal biofilm growth conditions.  
 
For optimal biofilm growth, cultures were then diluted 1:100 and grown overnight in 96-
microwell plates in 37 ˚C and 220 rpm aeration. Shorter incubation times for biofilm 
development have also been described in the literature, but overnight incubation was 
chosen to ensure proper attachment (Peeters et al. 2009). Biofilms were grown in 200 µl 
volume per well, or when measuring luminescence using the CellTiter-Glo® assay (see 
section 4.5.2) 100 µl of bacteria per well was used. 
 
4.2.2 Viable count determination 
 
Quantifying the colony forming units per millilitre (CFU/ml) was done by plating serial 
dilutions of bacterial culture on a LB agar plate. A sample was taken from the desired 
culture, and then diluted subsequently ten-fold up to 8 times. Each dilution was plated on 
a quarter of a LB agar plate in five 10 µl drops and incubated in 37 ˚C (Figure 2). After 
an appropriate incubation time, usually 48 hours, the colonies from each drop were 
counted and an average number of colony forming units was calculated for each dilution 
with distinguishable colonies.  
 
 
Figure 2. An example of 48-hour old colonies on a LB agar plate for viable count 
determination. 
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The count for colony forming units per one millilitre was calculated by dividing the 
average number of colonies in a drop with the dilution factor of the sample. Only two 
adjacent countable dilutions were included in the calculations. The formula for viable 
count determination is shown below. 
 
Viable count = (Average colony count × Dilution factor) / Drop volume. 
 
4.2.3 Quantitation of remaining persisters after treatment 
 
To quantify persisters after treatment, a plating method was carried out according to a 
protocol by Vandecandelaere et al. (2016). Flat-bottomed, clear 96-microwell plates were 
used. Biofilms were grown to maturation (see section 4.2.1) in 100 µl volumes and treated 
with 120 µl of ciprofloxacin and doxycycline (0.1 × MBIC, 4 × MBIC and 10 × MBIC) 
for 24 hours. After exposure, the antibiotic solutions were removed and wells were 
washed with PBS and finally 100 µl of PBS was added to each well. The plate was sealed 
and sonicated for 5 minutes. The cells from 4 replicate wells were transferred to one 
Eppendorf tube, and sonication was repeated with 100 µl of PBS. These cells obtained 
with the second sonication were combined with the previous ones in the same Eppendorf 
tube. The tubes for each sample were centrifuged at 5000 rpm for 10 minutes. Supernatant 
was removed and 1 ml of PBS was added. Ten-fold serial dilutions were made and drops 
were plated on LB agar plates as described previously and the number of colonies was 
calculated. 
 
4.2.4 Resazurin staining 
 
Resazurin (7-Hydroxy-3H-phenoxazin-3-one 10-oxide) is a redox dye that can be used in 
biological assays to evaluate the amount of viable bacteria present (Sandberg et al. 2009). 
Non-fluorescent blue resazurin is reduced to pink highly-fluorescent resorufin when 
metabolically active bacteria are present. This reaction can be observed visually, or it can 
be measured spectrophotometrically or the fluorescence can be measured, which was the 
chosen method in this case due to the high sensitivity of the method. Before measurement 
the planktonic phase was transferred to a separate plate and the biofilms were washed 
with PBS to remove any loosely attached bacteria and 200 µl of 0.4 mM resazurin was 
added in each well on a 96-microplate. When staining planktonic bacteria, it was 
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transferred to a separate plate and resazurin was used in a final concentration of 20 µM, 
by addition of 10 µl of the 0.4 mM resazurin stock solution into the bacteria solution. It 
was observed, that a 2-hour incubation after resazurin addition was needed for sufficient 
reduction of resazurin in biofilm cultures, planktonic cultures required less exposure time. 
The plates were incubated with 220 rpm aeration in room temperature in darkness. For 
evaluating the viability of B. cenocepacia cultures, fluorescence was measured with 
Varioskan LUX at the excitation wavelength of 560 nm and emission wavelength of 590 
nm. 
 
4.2.5 CellTiter-Glo® Luminescent Cell Viability Assay 
 
Cell viability was also evaluated with a commercially available CellTiter-Glo® 
Luminescent Cell Viability Assay kit. With this method, it is possible to measure the level 
of viable cells in culture, since the level of ATP correlates with the viability of the cells 
and the method is based on measuring ATP levels. The assay is designed for eukaryotic 
cells, but it was applied for gram-negative bacterial species of B. cenocepacia in this 
study. Assay was carried out according to the manufacturer’s instructions (Promega, 
2015).  
 
The bacteria were grown as described earlier, and 100 µl volume of bacterial suspension 
was used to grow the biofilms on the microwell plates. ATP references for standard curves 
were always prepared freshly as ten-fold dilution series from the 10 µM stock solution. 
All luminescence experiments were carried out on white bottomed microwell plates to 
prevent the signal from leaking to neighbouring wells. This is a simple method to 
determine the number of viable, metabolically active cells in culture by quantitation of 
the ATP present. The assay kit is designed for multiwell-plate formats, and it is suitable 
for high-throughput screening (HTS). The assay is performed by mixing the substrate and 
buffer components together and adding the mixture in the wells of a 96-mwp containing 
the cells. Adding the mixed reagent in a cell culture results in cell lysis and generates a 
stable luminescent signal proportional to the amount of ATP present. The assay is based 
on the properties of a luciferase enzyme (Ultra-Glo™ Recombinant Luciferase) which 
creates a luminescent signal when ATP is present (Figure 3). Luminescence measurement 
was carried at 1000 nm with Varioskan LUX plate reader.  
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Figure 3. The luciferase reaction. In the presence of ATP, molecular oxygen and Mg+ 
luciferase catalyses mono-oxygenation of luciferin (CellTiter-Glo® Luminescent Cell 
Viability Assay protocol, Promega, 2015) 
 
 
4.2.6 Crystal violet staining 
 
To determine the biomass of the biofilm, crystal violet staining was carried out. The 
protocol was adapted from the articles Sandberg et al. 2008 and Skogman et al. 2012.  
200 µl of bacteria were grown to biofilm as described earlier and after incubation the 
planktonic phase was removed carefully and the remaining biofilm was washed with MQ-
water. The biofilm was fixed with 200 µl of methanol and incubated in room temperature 
for 15 minutes before methanol was removed and let evaporate to dryness. 190 µl of 1:100 
diluted crystal violet was added and let stain for 5 minutes. Stain was removed and 
washed twice with MQ-water and dried. Finally, the stain was solubilized in 96 % ethanol 
and incubated for at least one hour before measuring the results at wavelength 595 nm. 
The assay was carried out in room temperature. 
 
4.2.7 Susceptibility testing 
 
First, susceptibility testing for three antibiotics, doxycycline, ciprofloxacin and 
tobramycin was carried out. The lowest concentration of antibiotics to inhibit bacterial 
growth both in planktonic and biofilm forms of the bacteria were determined. All 
concentrations of antibiotics were prepared in two replicates and all experiments were 
done twice. Antibiotic stocks were prepared in water (doxycycline, tobramycin) or in 
dimethyl sulfoxide (DMSO) (ciprofloxacin). The stock solutions were serially diluted 2-
fold in LB, to achieve final well concentrations of 1,024 – 4.88 × 10-7 mg/ml. The bacteria 
were grown to mid-exponential phase as described earlier. After incubation, this culture 
suspension was diluted 1:100 to achieve concentration 4 × 106 CFU/ml and then 
transferred into the microplate with the antibiotics as a total volume of 200 µl per well. 
25 
 
 
The plates were incubated for 24 hours in 37 °C with 220 rpm aeration. After the 
incubation, the plates were visually inspected and the planktonic phase was transferred to 
a clean microplate. Optical density was measured with Varioskan LUX at a wavelength 
595 nm to confirm the visual MIC values. To establish minimum biofilm inhibitory 
concentrations (MBIC) for each antibiotic, resazurin staining and crystal violet staining 
were carried out. An inhibition percentage was calculated from resazurin experiment for 
two replicate wells using the formula shown below, percentages over 90 % were 
considered inhibitory.  
 
Inh-% = 100 × (µ Control – µ Sample) / (µ Control – µ Medium). 
 
After resazurin staining, biofilm mass was measured with crystal violet. This method 
measures the biomass of the biofilm, but does not separate the living cells from other 
biomass. 
 
A post exposure experiment was carried out to see how the antibiotics eradicate mature 
biofilm. The biofilms were pre-grown, then the antibiotics were added on the biofilm after 
replacing the planktonic phase with fresh media and the plates were incubated for 
additionally 24 hours. Resazurin and crystal violet were used subsequently to evaluate 
the minimum inhibitory concentrations. 
 
A dose-response chart was created for an established anti-persister compound; Mitomycin 
C (MMC). First the biofilms were grown for 18 hours, and after washing with PBS, MMC 
was added with fresh media. The mature biofilms were exposed to MMC for 24 hours 
before using the CellTiter-Glo® assay kit to measure luminescence. 
 
4.2.8 Statistical methods for assay validation 
 
To be able to evaluate the comparability and repeatability of biological assays, statistical 
parameters like Z’ (screening window coefficient) together with S/B (signal to 
background) and S/N (signal to noise) should be calculated (Fallarero et al. 2014). This 
improves the uniformity of biological assays.  Screening window coefficient Z’ can be 
used to evaluate the performance of the assay, and it was calculated using formula shown 
below. Z’ is measured with controls only, and the value should be 0.5–1.0. 
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𝒁′ = 𝟏 −
 𝟑(𝝈 𝑪𝒐𝒏𝒕𝒓𝒐𝒍 +  𝝈 𝑴𝒆𝒅𝒊𝒖𝒎)
|𝝁 𝑪𝒐𝒏𝒕𝒓𝒐𝒍 +  𝝁 𝑴𝒆𝒅𝒊𝒖𝒎|
 
 
To supplement the Z’ factor, performance of an assay can be assessed with S/B which 
should be > 2, and S/N (the higher the better) which measures how robustly maximum 
and minimum signals can be differentiated. Both values are calculated with control only 
and the formulas are shown below. 
 
𝑺
𝑩
=
µ 𝒎𝒂𝒙
µ 𝒎𝒊𝒏
 
 
𝑺
𝑵
=  
µ 𝒎𝒂𝒙 − µ 𝒎𝒊𝒏
√𝑺𝑫𝒎𝒂𝒙𝟐𝟐 + 𝑺𝑫𝒎𝒊𝒏𝟐
 
 
Also, to assess the variations between days and plates, CVA% was calculated. To have 
good repeatability the value should be under 20 %.  
 
𝑪𝑽𝑨 % =  
𝑺𝑫 𝒎𝒂𝒙
µ 𝒎𝒂𝒙 − µ 𝒎𝒊𝒏
 × 𝟏𝟎𝟎 % 
 
For susceptibility testing, IC50 value was calculated using GraphPad Prism 7 (for mac) 
and % of inhibition was calculated with the formula presented below.  
 
% 𝒐𝒇 𝒊𝒏𝒉𝒊𝒃𝒊𝒕𝒊𝒐𝒏 =  
µ 𝒎𝒂𝒙 − µ 𝒔𝒂𝒎𝒑𝒍𝒆
µ 𝒎𝒂𝒙 − µ 𝒎𝒊𝒏
 ×𝟏𝟎𝟎 % 
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5 RESULTS AND DISCUSSION 
 
The goal was to develop a screening method for detecting anti-persister activity in B. 
cenocepacia biofilms. Since the species was new to the lab, the growth conditions had to 
be optimized before establishing a screening method. Optimizing an assay is challenging 
and requires major effort. Following the growth optimization, susceptibility testing was 
carried out for three model antibiotics (ciprofloxacin, doxycycline, tobramycin) as well 
as MMC, an established anti-persister compound. Dormant persisters are a small fraction 
of the bacterial population, and a method for detecting even the slightest metabolic 
activity was needed. The lack of a good assay for persisters was the driving force for this 
thesis. Several methods were tried out to evaluate the amount of persisters cells, and one 
of those was deemed as successful for the purpose. 
 
5.1 Burkholderia cenocepacia biofilm growth optimization. 
 
The growing of B. cenocepacia biofilms is well described in the literature but further 
optimization of the experimental conditions is typically needed when used for the first 
time  (Buroni et al. 2014; Van Acker et al. 2013). It was observed that bacteria grew quite 
slowly in narrow 15 ml tubes, and larger 50 ml centrifuge tubes were used for faster initial 
grow of the bacteria. A wider tube most likely enabled a better oxidation of the culture. 
After overnight incubation, the pre-culture was diluted 1:10 to achieve exponential 
growth in four hours. All higher dilutions experimented (1:20, 1:50 and 1:100) took more 
than four hours to reach the desired turbidity of 0.3 – 0.5. The concentration of bacteria 
in this optical density was determined with viable count determination, and it contained 
approximately 4 × 108 CFU/ml. 
 
Different dilutions of mid-exponential culture were experimented for biofilm growing 
and the biofilm growth was assessed with resazurin and crystal violet staining. Also, the 
effect of washing the biofilms after planktonic phase removal prior to staining was 
studied. The dilution of 1:100 resulted in good statistical parameters (Z’ > 0.5) with or 
without washing. Although the dilution of 1:10 without washing would give the best Z’ 
value, the washing step was included to ensure an efficient removal of the planktonic 
bacteria and due to additional reasons, as indicated below. Resazurin staining proved to 
be a steady method for assessing the viability of the biofilm. For further experiments this 
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dilution (1:100) of the exponential culture was selected for biofilm growing, and 
measurement were carried out with resazurin staining with the washing step included 
(Table 1). 
 
Table 1. Statistics of different conditions tested for biofilm growth. Measurements were 
carried out with resazurin staining. RSD = Relative standard deviation. 
Dilution wash Z' RSD% 
1 yes 0.61 10.85 
1  no 0.47 16.18 
10 yes 0.49 14.02 
10 no  0.84 4.63 
100 yes 0.66 8.99 
100 no  0.52 14.17 
 
The washing step was also included because when studying persisters in further 
experiments, mainly the persisters in biofilm would be of interest. Persisters are not 
unique to biofilms, but the planktonic phase contains significantly less persisters (Van 
Acker et al. 2013). The statistical parameters for the lower dilution (1:10) with no washing 
were slightly better, because it would contain more bacteria (some planktonic bacteria in 
addition to the biofilm), but as the planktonic bacteria are not of interest and the biofilm 
of this concentration was not as well attached as the selected one. 
 
In addition to appropriate temperature and aeration, e. g. concentration and incubation 
time of the culture affects the properties of the biofilm, like attachment, growth rate and 
viability. It was also noted, also the volume of the centrifuge tube in initial grow can make 
a difference in the growth speed. Although the culturing of a certain bacteria is described 
in the literate, it is always important to optimize the protocol for the lab. 
 
5.2 Cultivating B. cenocepacia static cultures. 
 
Because stationary cultures are known to contain more persister cells or cells behaving 
exactly like persisters, an assay was carried out to achieve stationary phase in B. 
cenocepacia planktonic cultures (Luidalepp et al. 2011; Van Acker et al. 2013). The 
overnight grown pre-culture was diluted ten-fold and growth was then measured by viable 
count determination on LB agar plates after 5, 24, 48, 72, 96 and 120 hours of incubation. 
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Staphylococcus aureus cultures achieve static conditions after an 18-hour incubation 
(Miettinen et al, unpublished results). The assumption was, that the B. cenocepacia 
culture would enter also a stationary phase after several hours of incubation without any 
nutrient addition. The culture did grow 2 log10 from the first measurement point (5 hours) 
to 24 hours and then the number of culturable colonies decreased to starting concentration 
after 48 hours of incubation (Figure 4). Any plating done after this (72 – 120 hours), did 
not produce colonies on the LB agar plates.  
 
The static cultures were stained with resazurin at time points 24, 48, 72 and 96 hours to 
evaluate how metabolically active the cultures were. All measured time points did 
produce a detectable fluorescence signal with the resazurin dye, except the 96-hour old 
culture, which had the least metabolic activity as the signal was close to background 
signal from media. Fluorescence (RFU) describing the metabolic activity measured with 
resazurin dye was almost the same in 48 and 72-hour old cultures, although the 72-hour 
culture did not grow at all on the LB agar plates (Figure 4). This phenomenon could be 
explained by the viable but non culturable (VBNC) state of bacteria. After two days of 
incubation, it seems that some critical changes in the environmental conditions occur that 
promotes the bacteria to enter this dormant state within a day. VBNC state can be induced 
by various environmental factors (Ayrapetyan et al. 2015). 
 
 
Figure 4. Fluorescence (Relative fluorescence units, RFU) of static cultures and 
equivalent CFU/ml of the equal cultures. 
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More accurate growth curve could be possibly obtained with the CellTiter-Glo® 
Luminescent Cell Viability Assay kit, which can detect even low amount of living 
bacteria, and the results can be scaled to equivalent number of colony forming units. 
 
5.3 Finding a method for studying anti-persister activity 
 
The aim of the study was to develop a method that would be suitable for anti-persister 
screenings on B. cenocepacia biofilms. The assay developed should be sensitive to low 
amounts of living bacteria, as persisters are only a small fraction of the population. The 
assay should also be repeatable and multi-well plate compatible. Several methods were 
tried out and the results are presented and discussed below. Resazurin staining is a simple 
protocol for determining the viability of the bacterial culture, but it proved to be too 
insensitive for detecting small fractions of living bacteria. Second tested method was a 
protocol by Vandecandelaere (2016), to isolate the persisters from culture by plating 
method. This however is not suitable for B. cenocepacia since non-culturable bacteria 
may interfere with the results due to long incubation times. Third experiment explored 
proved to be sensitive to even low number of bacteria and is easy to conduct. Many anti-
persister strategies target metabolism activation, like the uptake of 
antibiotics/aminoglycosides or re-awaking the persisters (Allison et al. 2011).  
 
5.3.1 Evaluating metabolic activity with resazurin 
 
The amount of surviving persisters after treatment was first evaluated using resazurin 
staining. This assay has been extensively utilized in the laboratory  (Skogman et al. 2012), 
and it was a logical choice to begin with. First, the suitable incubation time for resazurin 
had to be optimized and 24, 48 and 72 hour old cultures were measured to study the signal 
development. A 2-hour incubation time was sufficient for resazurin staining of B. 
cenocepacia biofilms (Figure 5). The experiment was carried out with planktonic cells 
from the static cultures and it was taken into account that planktonic cells stain faster than 
biofilms. 
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Figure 5. Development of fluorescence signal in resazurin staining of static cultures. 
 
 
Resazurin staining was carried out to measure the amount of viable bacteria in the culture. 
Overnight grown biofilms were treated with antibiotics ciprofloxacin and doxycycline at 
concentrations 0.1, 4 and 10 × MBIC and biofilms were exposed to these substances for 
2 hours and 24 hours. This method however did not bring out expected results, as the 
signal were significantly lower and detection limit for resazurin seems to be relatively 
high. For S. aureus, the detection limit is around 5 × 107 (Sandberg et al. 2009) and it can 
be assumed that it is at the same magnitude for B. cenocepacia. 
 
5.3.2 Quantitation of persisters after treatment by viable count determination 
 
Persister cells were isolated from biofilms grown on microplates and treated with 
antibiotics according to a previously published protocol for quantifying persisters from 
biofilms (Vandecandelaere et al. 2016). The viable count determination was conducted to 
calculate the viable counts (CFU/ml) after treatment. The results of different 
concentrations of ciprofloxacin and doxycycline (expressed as multiples of MBIC) are 
seen on Figure 6. A surviving fraction can be seen in 24-hour ciprofloxacin exposure 
(Figure 6b). However, it is uncertain how much undetectable VBNC bacteria there are.  
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The result from 24-hour doxycycline exposure show a larger surviving population, which 
might not all be persisters (Figure 6a). Considering that these bacteria seem to enter the 
viable but non culturable state, it is not an acceptable method to quantify persister cells. 
This method required long incubation times and harsh treatment like centrifuging, and it 
is uncertain how well the cells can tolerate that. There should be a larger difference 
between the results of different concentrations.  
 
 
Figure 6. Number of remaining cells (CFU/ml) after a. doxycycline treatment, b. 
ciprofloxacin treatment 
 
 
Also, the are a few problems with the protocol as such. The supernatant removal after 
centrifugation is too vulnerable for pipetting error, since the pellet is not solid and some 
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bacteria can be aspirated easily. Colony count is not a reliable method for anti-persister 
screening, because this bacteria strain may enter the VBNC state after 2 days of 
cultivation, as seen in the attempt to make a growth curve with plating method (Figure 
4). This method requires long incubation times and the risk for the bacteria to enter non-
culturable state is too high for the results to be reliable. It was also concluded, that 
ciprofloxacin treatment exposure time should be 24 hours, since the difference between 
2-hour and 24-hour exposure is evident. 
 
5.3.3 Evaluating metabolic activity by measuring ATP 
 
CellTiter-Glo® assay kit was utilized to evaluate the amount of ATP present in the treated 
cultures. The assay is based on the ability of luciferase enzyme to generate a stable 
luminescence signal when ATP is present in the cultures. This assay was carried out using 
three different compounds, ciprofloxacin, doxycycline and mitomycin C. The latter one 
was the most effective compound, as anticipated. The luminescence signal does not by 
itself tell how many bacteria there is in the culture as in the plating method, but the signal 
is proportional to the amount of viable bacteria in the culture. To evaluate the number of 
viable bacteria, a standard curve was calculated from ATP stock solution (Figure 7). 
Following the standard curve, the bacteria was grown to exponential phase, with known 
concentration of bacteria without the fear of non-culturable bacteria, and the 
luminescence of a ten-fold dilution series was measured (Figure 8).  
 
 
Figure 7. A standard curve for the luminescence signal from known amount of ATP. 
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Figure 8. The number of colony forming units corresponding to luminescence signal 
obtained. Detection limit was determined to be 4.6 × 105 CFU/ml in these assay 
conditions. 
 
 
By combining the data from Figure 7 and Figure 8, it is possible to determine the number 
of viable cells per millilitre in treated cultures (Figure 9). However, the plate count and 
the luminescence measurement for reference are made with exponentially growing 
bacteria (Figure 8). This might not be completely comparable to the situation of mature 
biofilms which have slower metabolism than in the bacteria in exponential phase. As 
explained earlier in chapter 5.2, the plate counts cannot be made from mature biofilms, 
as the presence of VBNC is unclear. The data in Figure 9 can be used to evaluate the 
changes in bacterial concentrations in cultures, and approximate the number of bacteria 
without plating and counting the colonies. Detection limit (4.6 × 105 CFU/ml) was 
determined to be the lowest measurement point where S/N was > 2 (2.71). 
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Figure 9. The number of colony forming units can be calculated from the amount of ATP 
present in the culture. This can be done by measuring the luminescence of cultures and 
combining the data with the standard curve. 
 
 
To evaluate performance of the CellTiter-Glo® assay, screening window coefficient Z’ 
was calculated with formula shown in chapter 4.2.8. Statistical parameters between plates 
and days S/N were 8.95 – 12.82, S/B 712 – 775 and Z’ 0.66 – 0.77. Assay coefficient 
variations (CVA %) were 7.80 – 11.17 %. CVA % and Z’ can be used to estimate assay 
performance and variation between days and plates (Fallarero et al. 2014; Iversen et al. 
2006). 
 
The best option of the three methods described here turned out to be measuring the 
amount of ATP present in the treated cultures using CellTiter-Glo®. The method proved 
to be sensitive, and it can also detect non-culturable cells, the detection limit was 4.6 × 
105 CFU/ml for B. cenocepacia (Figure 8). With this method, the metabolic activity in 
the biofilm can be measured and the number of metabolically active cells estimated. 
When exposing cultures in micro wells to bactericidal concentrations of antibiotic, almost 
no free-floating bacteria is left and the planktonic phase can be removed before adding 
the luminescent reagent. Because all living cells contain ATP, culturable cells or not, 
VBNC bacteria do not interfere with this method. The CellTiter-Glo® assay kit is 
designed for eukaryotic cells, thus the reliability of the assay in gram-negative bacteria 
had to be assessed. CellTiter-Glo® assay kit was selected for availability reasons, 
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although there is also available a similar assay kit suitable for bacteria (BacTiter-Glo®). 
The reagent in the CellTiter-Glo® assay was observed to lyse gram-negative bacteria and 
give a high signal although it is designed for eukaryotic cells. This is a sensitive, 
repeatable method that can detect alive persister cells from cultures treated with 
bactericidal concentrations of antibiotics.  
 
5.4 Susceptibility testing 
 
5.4.1 Determining minimum inhibitory concentrations for antibiotics 
 
To study persisters alone, they have to be isolated from the normal population. This can 
be done by killing the non-dormant population with bactericidal concentration of an 
antibiotic (Keren et al. 2004). Only dormant, non-dividing persister cells survive the 
bactericidal concentrations of antibiotics. In order to know this concentration, MIC 
(minimum inhibitory concentration) and MBIC (minimum biofilm inhibitory 
concentration) values were determined for doxycycline, ciprofloxacin and tobramycin. 
Antibiotics (tobramycin and ciprofloxacin) were chosen from previous studies found in 
the literature (Buroni et al. 2014; Van Acker et al. 2013) 
 
Susceptibility testing was done using turbidity measurement, resazurin staining and 
crystal violet staining. All experiments were done twice, and the resazurin staining 
method was chosen for the calculations of the MBIC values (Figure 10). Biofilms were 
grown in the presence of antibiotics for 24 hours before measurement and inhibition 
values of 90 % or more were considered inhibitory. MBIC for doxycycline, ciprofloxacin 
and tobramycin were 16 µg/ml, 8 µg/ml and 256 µg/ml, respectively (n = 2). Determined 
MBIC values were similar with values found in literature (Buroni et al. 2014; Van Acker 
et al. 2013).  
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Figure 10. An example of a resazurin stained 96-microplate when determining MBIC. 
The change of colour is easy to detect even visually. Fluorescence measurement was 
carried out for results. 
 
 
The MIC values were evaluated visually and confirmed by measuring the optical density. 
MIC values for doxycycline, ciprofloxacin and tobramycin were 8 µg/ml, 4 µg/ml and 
256 µg/ml respectively (n = 2), results were the same when experiment was repeated, and 
Z’ was always above 0.5.  
 
In addition, overnight grown biofilms were treated with antibiotics similarly as in 
determining MBIC. It is more realistic to expose the mature biofilms to antibiotics when 
evaluating the efficacy of antibiotics. It is clear that it is more difficult to eradicate a 
mature biofilm with antibiotic, than preventing biofilm from growing in the presence of 
an antibiotic. Susceptibility testing is usually done as pre-exposure experiment, but it is 
not the most realistic way to evaluate the efficacy of an antibiotic. Almost no 
concentration of antibiotics applied could eradicate the mature biofilm in this experiment. 
The overnight grown biofilm may slow down the penetration of the antibiotics, and also 
the dormant persisters that are more abundant in biofilms than in planktonic bacteria, are 
not killed by the antibiotic. Many antibiotics corrupt the proteins produced by a 
metabolically active cell, thus dormant cells are not affected by bactericidal antibiotics 
(Lewis 2010). Resistant bacteria block the antibiotic from binding, but tolerant bacteria 
prevent the cascade of event leading to corrupted proteins from happening. 
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5.4.2 Antibiotic treatment of mature biofilms 
 
The effect of two antibiotics against overnight grown biofilms were assessed using 
CellTiter-Glo® luminescent assay kit. Ciprofloxacin is a broad-spectrum fluoroquinolone 
antibiotic, which inhibits bacterial DNA replication, more specifically the ligase step of 
the DNA gyrase and topoisomerase IV resulting in cell lysis (Fisher et al. 1989; Hooper 
2002). It was developed for clinical use in the 1980’s to treat infections due to gram-
negative bacteria and has also limited effect against some gram-positive bacteria. 
Doxycycline is a half-synthetic broad-spectrum tetracycline antibiotic, which inhibits 
protein synthesis by binding to bacterial ribosome (Nelson and Levy 2011). 
 
Overnight grown biofilms were treated with ciprofloxacin and doxycycline with different 
concentrations, and the growth inhibition was assessed using CellTiter-Glo® 
Luminescent assay. Concentrations of antibiotics were selected according to the 
susceptibility testing carried out earlier. As seen in Figure 11, doxycycline is unable to 
eradicate mature biofilm even at high concentrations. However, ciprofloxacin is much 
more effective, being able to kill most of the biofilms.  
 
 
Figure 11. Inhibition-% of different concentrations of doxycycline and ciprofloxacin after 
24-hour exposure. 
 
 
In addition to these antibiotics, the inhibitory effect of another interesting compound, 
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biofilms (Miettinen, unpublished results), but as expected with gram-negative bacteria, 
DHA did not have any inhibitory effect on B. cenocepacia biofilms even at high 
concentrations. 
 
5.4.3 Biofilm eradication with Mitomycin C 
 
Mitomycin C (MMC) is an established anti-persisters compound, and the effect against 
B. cenocepacia biofilms was tested with two concentrations (400 µM and 100 µM) using 
the CellTiter-Glo® assay. The two concentrations tested show high activity against 
overnight grown biofilms and as there are no published results so far of MMC activity 
against B. cenocepacia biofilms, a killing curve was established (Figure 12).  
 
 
Figure 12. Killing of mature biofilms with Mitomycin C after 24-hour exposure.   
 
 
The MMC solutions in concentration 400 µM–0.01 µM were prepared in DMSO, so that 
the final DMSO concentration was always < 5 %, which had no effect on the results. 
MMC is a chemotherapeutic agent which is known to kill persister cells by damaging the 
DNA (Kwan et al. 2015). There are no previous results or experiments on MMC 
eradicating B. cenocepacia biofilms. These results prove that MMC kills B. cenocepacia 
biofilms even at very low concentrations. IC50 value was calculated to be 0.756 µM (0.183 
– 3.13 with 95 % confidence interval). IC50 value can be used to evaluate the potency of 
anti-biofilm effect of the compound.  
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Figure 13. Mitomycin C. (modified from PubChem) 
 
 
MMC passively diffuses into cells as an amphipathic molecule. When it enters the 
reducing environment of bacterial cytoplasm, the quinone functional group of the 
compound is reduced spontaneously initiating cross-linking of two opposing DNA 
strands. MMC kills non-persister and VBNC cells also (Kwan et al. 2015). Traditional 
antibiotics (fluoroquinolones, aminoglycosides and β-lactams) are ineffective against 
persisters cells owing to their mechanism relying on cellular activity. MMC is effective 
because of its unique mechanism. 
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6 CONCLUSIONS AND FUTURE PERSPECTIVES 
 
Conventional antibiotics are typically not effective against chronic infections and 
difficulties in the treatment of acute infections are increasing. As the need for new 
antibiotics is evident, and resistance is evolving faster than the discovery of new 
antimicrobials, new approaches for counteracting microbial infections should be 
developed. Persisters have been identified as a main problem in biofilm related infections, 
and antibiotics targeting growing and dividing cells are unable to kill persisters. 
 
In this thesis, a promising method was developed and validated for detecting anti-persister 
activity against B. cenocepacia. The assay is based on measuring the levels of ATP 
present in the cultures after treatment and it can be used quantify remaining persisters 
after treatment using B. cenocepacia biofilms. The method is suitable for high-throughput 
screening and it is sensitive. Otherwise promising method utilizing resazurin staining 
proved to be too insensitive for detecting small amounts of persister cells.  Viable count 
determination had consistency deficiencies, as the culturability of the bacteria may be 
affected during the experiment. 
 
Utilizing the method validated, it was confirmed that mitomycin C (MMC) is an effective 
anti-persister compound against highly tolerant B. cenocepacia biofilms even at low 
concentrations. These bacteria, especially in the biofilm state, are intrinsically tolerant 
against many antimicrobials and cause severe infections in immunocompromised people. 
Doxycycline is ineffective against B. cenocepacia biofilms, although the bacteria are 
susceptible to it in planktonic form, and ciprofloxacin is effective at very high 
concentrations. 
 
The curious bacterial phenotype of persisters needs more investigation and validated 
methods for the research of anti-persister compounds. Well validated screening methods 
would able the studies for new anti-persister compound leads and further drug 
development. 
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